Harmony Biosciences Holdings Inc. (HRMY) Social Stream
HARMONY BIOSCIENCES HOLDINGS INC (HRMY) Price Targets From Analysts
Use the tables below to see what analysts covering HARMONY BIOSCIENCES HOLDINGS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-28 | 4 | $58 | $54 | $56.5 | $32.59 | 73.37% |
| 2022-02-01 | 5 | $60 | $55 | $57.4 | $32.59 | 76.13% |
| 2022-03-01 | 5 | $58 | $55 | $56.8 | $32.59 | 74.29% |
| 2022-04-10 | 6 | $59 | $55 | $57.2 | $32.59 | 75.51% |
| 2022-05-04 | 6 | $63 | $55 | $58.166 | $32.59 | 78.48% |
| 2022-05-10 | 6 | $63 | $55 | $57.833 | $32.59 | 77.46% |
| 2022-07-14 | 8 | $64 | $55 | $59.125 | $32.59 | 81.42% |
| 2022-08-03 | 8 | $64 | $55 | $59.125 | $32.59 | 81.42% |
| 2022-08-04 | 7 | $69 | $55 | $61.285 | $32.59 | 88.05% |
| 2022-10-13 | 7 | $69 | $55 | $61.285 | $32.59 | 88.05% |
| 2022-10-19 | 7 | $69 | $55 | $61.857 | $32.59 | 89.8% |
| 2022-10-21 | 7 | $69 | $51 | $61.285 | $32.59 | 88.05% |
| 2022-11-03 | 8 | $71 | $51 | $63.5 | $32.59 | 94.85% |
| 2022-11-30 | 8 | $71 | $51 | $64.75 | $32.59 | 98.68% |
| 2023-01-17 | 8 | $71 | $51 | $65.75 | $32.59 | 101.75% |
| 2023-02-22 | 8 | $71 | $51 | $66.375 | $32.59 | 103.67% |
| 2023-04-17 | 8 | $71 | $43 | $63 | $32.59 | 93.31% |
| 2023-04-27 | 9 | $71 | $35 | $59.888 | $32.59 | 83.76% |
| 2023-05-02 | 9 | $71 | $38 | $60.222 | $32.59 | 84.79% |
| 2023-06-06 | 9 | $75 | $38 | $60.666 | $32.59 | 86.15% |
| 2023-08-02 | 8 | $75 | $38 | $60.5 | $32.59 | 85.64% |
| 2023-08-14 | 8 | $72 | $38 | $58.875 | $32.59 | 80.65% |
| 2023-08-22 | 8 | $75 | $38 | $59.375 | $32.59 | 82.19% |
| 2023-09-07 | 9 | $75 | $38 | $59.333 | $32.59 | 82.06% |
| 2023-10-12 | 9 | $75 | $31 | $58 | $32.59 | 77.97% |
| 2023-10-13 | 9 | $75 | $27 | $56.777 | $32.59 | 74.22% |
| 2023-10-16 | 9 | $66 | $26 | $45.555 | $32.59 | 39.78% |
| 2023-10-26 | 9 | $59 | $26 | $42.444 | $32.59 | 30.24% |
| 2023-11-01 | 9 | $59 | $26 | $41.222 | $32.59 | 26.49% |
| 2023-11-02 | 9 | $59 | $27 | $41.444 | $32.59 | 27.17% |
| 2023-11-07 | 9 | $59 | $27 | $42 | $32.59 | 28.87% |
| 2023-12-01 | 9 | $59 | $27 | $42.222 | $32.59 | 29.56% |
The Trend in the Analyst Price Target
Over the past 133 days, HRMY's average price target has gone down $18.28.
HRMY reports an average of 77.21% for its upside potential over the past 46 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-20 | 9 | 71 | 35 | 59.888 | 31.680 | 89.04% |
| 2023-07-21 | 8 | 75 | 38 | 60.500 | 35.610 | 69.9% |
| 2023-07-25 | 8 | 75 | 38 | 60.500 | 36.450 | 65.98% |
| 2023-10-12 | 9 | 75 | 31 | 58.000 | 30.265 | 91.64% |
| 2023-10-13 | 9 | 75 | 27 | 56.777 | 21.110 | 168.96% |
HRMY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.89 | 5 | 2 | 1 | 1 | 1 | 9 |
The Trend in the Broker Recommendations
HRMY's average broker recommendation rating worsened by 0.39 over the prior 13 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, HARMONY BIOSCIENCES HOLDINGS INC's variance in analysts' estimates is lower than -1505.45% of them.
- HARMONY BIOSCIENCES HOLDINGS INC's upside potential (average analyst target price relative to current price) is greater than 2642.66% of all US stocks.
- In terms of how HARMONY BIOSCIENCES HOLDINGS INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is higher than 2622.18% of that group.
- In terms of how HARMONY BIOSCIENCES HOLDINGS INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 1777.2% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to HARMONY BIOSCIENCES HOLDINGS INC are ME, AVIR, and LMDX.
View All Top Stocks by Price Target
What is the outlook for HRMY? Use POWR Ratings for clearer insight into price direction.